SCHEMBL572086

SCHEMBL572086

COc1cc(OC)c(C2Cc3c(O)cc(O)cc3OC2=O)cc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.41
POLB P06746 2/20 0.41
RECQL P46063 1/20 0.41
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 1/20 0.40
PTPN1 P18031 1/20 0.39
PTGS1 P23219 2/20 0.39
MAPK14 Q16539 1/20 0.39
MMP2 P08253 4/20 0.39
MMP14 P50281 4/20 0.39
MMP7 P09237 2/20 0.39
DYRK1A Q13627 1/20 0.39
TP53 P04637 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP19A1 P11511 2/20 0.39
XDH P47989 2/20 0.39
CYP1A1 P04798 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP1B1 Q16678 2/20 0.39
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27882637 0.86 KMT2A (0.48) KMT2APOLBRECQLALDH1A1MEN1
SCHEMBL18740869 0.80 ALDH1A1 (0.48) KMT2APOLBRECQLALDH1A1MEN1
SCHEMBL28486759 0.78 PTGS1 (0.49) KMT2APOLBRECQLALDH1A1MEN1
SCHEMBL9993959 0.75 ESR1 (0.39) KMT2APOLBRECQLALDH1A1MEN1
SCHEMBL28259872 0.75 ALDH1A1 (0.47) KMT2APOLBRECQLALDH1A1MEN1
SCHEMBL3493652 0.73 ESR1 (0.55) KMT2APOLBRECQLALDH1A1MEN1
SCHEMBL572085 0.72 PTPN1 (0.67) KMT2APOLBRECQLALDH1A1MEN1
SCHEMBL17963720 0.72 KDM4E (0.56) KMT2APOLBRECQLALDH1A1MEN1
SCHEMBL27934854 0.65 TUBB4A (0.47) ALDH1A1TP53CYP3A4CYP19A1XDH
SCHEMBL13412722 0.65 CYP3A4 (0.38) KMT2AALDH1A1MEN1CYP3A4CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2014-08-21 US disclosed
US-8748177-B2 Compositions for proliferation of cells and related methods THE HOSPITAL FOR SICK CHILDREN (CA) 2014-06-10 US disclosed
EP-2598150-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS The Hospital For Sick Children (CA) 2013-06-05 EP disclosed
WO-2012018643-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2012-02-09 WO disclosed
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2011-12-08 US disclosed
WO-2010039679-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 KMT2A 2121/4885POLB 292/4885RECQL 1434/4885
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 KMT2A 2121/4885POLB 292/4885RECQL 1434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.